Generics increase competition: study

Share this article:
A new study funded by PhRMA says the increasing use of authorized generics by drug companies has not led to delays in generic entry into the marketplace. “This study and others show that authorized generics are increasing competition and helping lower prescription drug prices for patients, not harming competition,” said PhRMA VP, policy and research, Lori Reilly. “As a result, proposals to restrict authorized generics would reduce consumer savings.”

The study by an MIT professor and Analysis Group researchers reportedly confirmed that the  increase in generics had not reduced incentives to challenge brand name patents.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Legal/Regulatory

 

Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.